TAGRISSO® and Chemotherapy Combo Approved for EGFR-Mutated Lung Cancer AstraZeneca’s TAGRISSO® (osimertinib) combined with chemotherapy has secured approval in the US for treating adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).…
Henry Schein Launches ‘Prevention is Power’ Campaign Henry Schein, Inc. (Nasdaq: HSIC) unveils Prevention is Power™, a long-term public health awareness initiative led by the Henry Schein Cares Foundation, Inc. (HSCF). This campaign aims to enhance health literacy and encourage…
On Wednesday, Feb. 14, Ambetter from Sunshine Health joined forces with the Miami Dolphins to combat food insecurity in South Florida, providing essential food assistance to local families in need. Volunteers from Ambetter and the Miami Dolphins teamed up to…
Missouri Schools & Home State Health: Fostering Belonging on National No One Eats Alone® Day For the sixth consecutive year, Home State Health, a Managed Care Organization catering to Medicaid recipients in collaboration with MO HealthNet and a subsidiary of…
Meridian in Michigan, a prominent managed care organization and subsidiary of Centene Corporation (NYSE: CNC), has teamed up with the Wayne Mobile Health Unit (WMHU) to enhance maternal and infant health. This partnership extends support to WMHU’s community outreach initiatives,…
Improving North Carolinians’ Health: WellCare & Reinvestment Partners Collaborate Today, WellCare of North Carolina, a subsidiary of Centene Corporation (NYSE: CNC), unveiled a strategic collaboration with Reinvestment Partners. This partnership aims to leverage the expertise of Reinvestment Partners, a non-profit…
Armis , the asset intelligence cybersecurity company, today announced it has been named “Top Performer” in the 2024 Best in KLAS Software & Services Report for Healthcare IoT Security for the second year in a row got. The Best in KLAS report recognizes software…
Today, Revvity, Inc. (NYSE: RVTY) has unveiled the Signals ClinicalTM solution through its software and informatics division, Revvity Signals. This groundbreaking software-as-a-service (SaaS) platform is designed to revolutionize clinical trial data management, offering comprehensive insights to facilitate informed decision-making and…
Armis, a leading cybersecurity company specializing in asset intelligence, proudly announces its recognition as a top performer in healthcare IoT security for the second consecutive year in the 2024 “Best in KLAS” Software & Services Report. This esteemed accolade underscores…
Repare Therapeutics to Regain Global Rights to Camonsertib Following Collaboration Termination with Roche” Repare Therapeutics Inc. (Nasdaq: RPTX), a prominent clinical-stage precision oncology company, has announced its intention to reclaim global development and commercialization rights to camonsertib (RP-3500), a potential…
Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and its parent company, Otsuka Pharmaceutical Co., Ltd. (Otsuka), have disclosed the topline findings from the phase 3 clinical trial of AVP-786 aimed at treating agitation associated with dementia due to Alzheimer’s disease…
Medpace Holdings, Inc. (Nasdaq: MEDP) has released its financial results for the fourth quarter and full year ending December 31, 2023. Fourth Quarter 2023 Financial Highlights: Full Year 2023 Financial Highlights: Balance Sheet and Liquidity: Source link